Literature DB >> 8524316

Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor.

D W Leaman1, S Pisharody, T W Flickinger, M A Commane, J Schlessinger, I M Kerr, D E Levy, G R Stark.   

Abstract

The tyrosine kinase JAK1 and the transcription factors STAT1 and STAT3 are phosphorylated in response to epidermal growth factor (EGF) and other growth factors. We have used EGF receptor-transfected cell lines defective in individual JAKs to assess the roles of these kinases in STAT activation and signal transduction in response to EGF. Although JAK1 is phosphorylated in response to EGF, it is not required for STAT activation or for induction of the c-fos gene. STAT activation in JAK2- and TYK2-defective cells is also normal, and the tyrosine phosphorylation of these two kinases does not increase upon EGF stimulation in wild-type or JAK1-negative cells. In cells transfected with a kinase-negative mutant EGF receptor, there is no STAT activation in response to EGF and c-fos is not induced, showing that the kinase activity of the receptor is required, directly or indirectly, for these two responses. The data do not support a role for any of the three JAK family members tested in STAT activation and are consistent with a JAK-independent pathway in which the intrinsic kinase domain of the EGF receptor is crucial. Furthermore, data from transient transfection experiments in HeLa cells, using c-fos promoters lacking the STAT regulatory element c-sis-inducible element, indicate that this element may play only a minor role in the induction of c-fos by EGF in these cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8524316      PMCID: PMC231011          DOI: 10.1128/MCB.16.1.369

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  76 in total

Review 1.  Growth factor receptor tyrosine kinases.

Authors:  Y Yarden; A Ullrich
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

2.  Transcription activation by serum, PDGF, and TPA through the c-fos DSE: cell type specific requirements for induction.

Authors:  Z Siegfried; E B Ziff
Journal:  Oncogene       Date:  1989-01       Impact factor: 9.867

3.  Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing.

Authors:  A M Honegger; T J Dull; S Felder; E Van Obberghen; F Bellot; D Szapary; A Schmidt; A Ullrich; J Schlessinger
Journal:  Cell       Date:  1987-10-23       Impact factor: 41.582

Review 4.  Fos and Jun: the AP-1 connection.

Authors:  T Curran; B R Franza
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

5.  Transcriptional autoregulation of the proto-oncogene fos.

Authors:  P Sassone-Corsi; J C Sisson; I M Verma
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

6.  c-fos sequence necessary for basal expression and induction by epidermal growth factor, 12-O-tetradecanoyl phorbol-13-acetate and the calcium ionophore.

Authors:  T M Fisch; R Prywes; R G Roeder
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

7.  Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene.

Authors:  T J Velu; L Beguinot; W C Vass; M C Willingham; G T Merlino; I Pastan; D R Lowy
Journal:  Science       Date:  1987-12-04       Impact factor: 47.728

8.  The c-fos serum response element responds to protein kinase C-dependent and -independent signals but not to cyclic AMP.

Authors:  M Z Gilman
Journal:  Genes Dev       Date:  1988-04       Impact factor: 11.361

9.  A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization.

Authors:  V P Sukhatme; X M Cao; L C Chang; C H Tsai-Morris; D Stamenkovich; P C Ferreira; D R Cohen; S A Edwards; T B Shows; T Curran
Journal:  Cell       Date:  1988-04-08       Impact factor: 41.582

10.  Biological activities of EGF-receptor mutants with individually altered autophosphorylation sites.

Authors:  A Honegger; T J Dull; F Bellot; E Van Obberghen; D Szapary; A Schmidt; A Ullrich; J Schlessinger
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

View more
  50 in total

1.  Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors.

Authors:  H Chen; J M Lee; Y Zong; M Borowitz; M H Ng; R F Ambinder; S D Hayward
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Protein kinase PKR is required for platelet-derived growth factor signaling of c-fos gene expression via Erks and Stat3.

Authors:  A Deb; M Zamanian-Daryoush; Z Xu; S Kadereit; B R Williams
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

3.  Chromatin acetylation and remodeling at the Cis promoter during STAT5-induced transcription.

Authors:  Anne Rascle; Emma Lees
Journal:  Nucleic Acids Res       Date:  2003-12-01       Impact factor: 16.971

Review 4.  STAT signaling in polycystic kidney disease.

Authors:  Sebastian Strubl; Jacob A Torres; Alison K Spindt; Hannah Pellegrini; Max C Liebau; Thomas Weimbs
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

5.  Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1.

Authors:  Tyler Lahusen; Mark Fereshteh; Annabell Oh; Anton Wellstein; Anna T Riegel
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

6.  Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation.

Authors:  J G Cheng; J R Chen; L Hernandez; W G Alvord; C L Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

7.  Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins.

Authors:  M L Vignais; H B Sadowski; D Watling; N C Rogers; M Gilman
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

8.  STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation.

Authors:  J Chung; E Uchida; T C Grammer; J Blenis
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

9.  Regulation of epidermal growth factor receptor in human colon cancer cell lines by interferon alpha.

Authors:  J-L Yang; X-J Qu; P J Russell; D Goldstein
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

10.  Epidermal growth factor and interleukin-1beta utilize divergent signaling pathways to synergistically upregulate cyclooxygenase-2 gene expression in human amnion-derived WISH cells.

Authors:  William E Ackerman; Brad H Rovin; Douglas A Kniss
Journal:  Biol Reprod       Date:  2004-08-25       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.